A Low Valuation, High Growth Target: ANI Pharmaceuticals
AlexLMX/iStock via Getty Images
ANI Pharmaceuticals (ANIP) is a company I have owned off and on the last three months. The enterprise has made a number of small deals to acquire existing drugs patents, some production assets, and the potential for new pharma…
